Clemastine clinical trials
How each study uses Clemastine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Clemastine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 25 Feb 1977 · TAVIST-1 · NDA 017661 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 12
University of California, San Francisco (5) · Qilu Hospital of Shandong University (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Chinese Academy of Medical Sciences, Fuwai Hospital (1) · LMU Klinikum (1) · Bridget LaMonica Ostrem, M.D., Ph.D. (1) · University of Illinois at Chicago (1) · Amsterdam UMC, location VUmc (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Antihistamines source
- One of Histamine H1 Antagonists source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test Clemastine.
- Nov 2026Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin PlasticityPhase 2 · LMU Klinikum
- Dec 2026Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life DepressionPhase 2 · University of Illinois at Chicago
- Jun 2027Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair TherapyPhase 1/2 · University of California, San Francisco
Studies
Open first, then newest update. How each study uses Clemastine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 13
- Neonatal White Matter Injury Trial (WRAP)RecruitingPhase 1Bridget LaMonica Ostrem, M.D., Ph.D.NCT07688746Written as Clemastine fumarateHow we know
- Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair TherapyRecruitingPhase 1/2University of California, San FranciscoNCT05359653Written as Clemastine FumarateHow we know
- Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life DepressionRecruitingPhase 2University of Illinois at ChicagoNCT06591091Written as Clemastine FumarateHow we know
- Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair TherapyNot yet recruitingPhase 1/2University of California, San FranciscoNCT06065670Written as Clemastine FumarateHow we know
- Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)RecruitingPhase 2University of California, San FranciscoNCT02521311Written as ClemastineHow we know
- Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin PlasticityNot yet recruitingPhase 2LMU KlinikumNCT06315972Written as clemastine (8 mg/day)How we know
- Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple SclerosisTerminatedPhase 3Amsterdam UMC, location VUmcNCT05338450Written as Clemastine FumarateHow we know
- Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams SyndromeCompletedPhase 2Qilu Hospital of Shandong UniversityNCT06315699Written as Clemastine Fumarate TabletsHow we know
- CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying TherapyCompletedPhase 2Cambridge University Hospitals NHS Foundation TrustNCT05131828Written as Metformin and clemastine in combinationHow we know
- Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple SclerosisCompletedPhase 2University of California, San FranciscoNCT02040298Written as ClemastineHow we know
- Clemastine in Cardiovascular SurgeryCompletedNot applicableChinese Academy of Medical Sciences, Fuwai HospitalNCT03826004Written as ClemastineHow we know
- Effect of Clemastine Fumarate on Color Vision in Healthy ControlsCompletedPhase 1University of California, San FranciscoNCT02613091Written as Clemastine fumarateHow we know
- Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic DermatitisStatus unknownPhase 3Azidus BrasilNCT01239719Written as Dexamethasone + clemastineHow we know
Given beside what is tested · 1 — Clemastine is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Clemastine
Codes
What other systems call Clemastine · ClinicalTrials.gg INT007226
- MeSH (NLM) D002974ClemastineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 95QN29S1IDCLEMASTINEConfirmed FDA, NLM, Wikidata
- RxNorm 2578Confirmed FDA, Wikidata
- Wikidata Q418145clemastineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61682ClemastineOne source FDA
- DrugBank DB00283One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002974 | Clemastine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 95QN29S1ID | CLEMASTINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2578 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418145 | clemastine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61682 | Clemastine | One source FDA |
| DrugBank | DB00283 | — | One source Wikidata |
Also registered as clemastine fumarate (UNII 19259EGQ3D · RxNorm 142430).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.